Assessment of graft function before liver transplantation: Quest for the lost ark?

Transplantation

Volumn 70, Issue 4, 2000, Pages 560-565

  Melendez, Hector Vilca ^a   Rela, Mohamed ^a   Murphy, Gerard ^b   Heaton, Nigel ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SECRETION; DRUG METABOLISM; ENERGY METABOLISM; ENZYME ACTIVITY; FUNCTIONAL ASSESSMENT; HUMAN; LIVER BIOPSY; LIVER FUNCTION; LIVER METABOLISM; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

EID: 0034721321     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200008270-00002     Document Type: Review

References (52)

1. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation
2. Retrieval team and national organization
3. Policies in Europe on 'marginal quality' donor livers
4. Understanding. 'Marginal' liver grafts
5. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation
6. Use of fatty donor liver is associated with diminished early patient and graft survival
7. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury
8. Hepatic protein synthesis rate of liver specimens as a predictor of viability in rat cold ischemia liver transplantation model
9. Metabolism during hepatic transplantation: Indicators of allograft function
10. Experimental studies of hepatic clearance rates of amino acids as an initial function test of the liver graft
11. Pretransplant assessment of human liver grafts by plasma lecithin: Cholesterol acyltransferase (LCAT) activity in multiple organ donors
12. Plasma lecithin/cholesterol acyltransferase (LCAT) activity in multiple-organ donors: A predictor of allograft viability in clinical liver transplantation
13. Reduced lecithin: Cholesterol acyltransferase (LCAT) and Na+, K+, ATPase activity in diabetic patients
14. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma
15. Lignocaine metabolite formation as a measure of pre-transplant liver function
16. Reliability of the MEGX test in the selection of liver grafts
17. The unreliability of the lidocaine/monoethylglycinexylidide test for assessment of liver donors
18. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability
19. Liver transplantation and bile analysis: A parallel evolution
20. A validated technique for the analysis of biliary bile acid secretion in donor livers prior to transplantation
21. Evaluation of hepatic excretory system function by determination of serum bile acid clearance early after liver transplantation
22. Early detection of graft dysfunction after orthotopic liver transplantation in man by serum and biliary bile acid analysis
23. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation
24. Hepatic transplantation survival: Correlation with adenine nucleotide level in donor liver
25. Energy charge as an indication of liver viability. A comparison of changes in livers that remained intact with those subjected to autografting
26. Can adenine nucleotides predict primary nonfunction of the human liver homograft?
27. The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation
28. Arterial ketone body ratio as a predictor of donor liver viability in human liver transplantation
29. Arterial ketone body ratio in clinical liver transplantation
30. Low-temperature fluorometric technique for evaluating the viability of rat liver grafts after simple cold storage
31. Role of free radicals and energy synthesis on primary graft nonfunction in liver transplantation
32. A simple method for assessment of mitochondrial viability in the liver graft
33. Molecular damage to rat liver mitochondrial H(+)-ATPase during cold preservation with UW solution
34. New evaluation method for viability of mitochondria in liver graft using fluorescent dye
35. Liver transplantation: Current and potential applications of magnetic resonance spectroscopy
36. 31P NMR assessment of orthotopic rat liver transplant viability. The effect of warm ischemia
37. Noninvasive metabolic assessment of human donor livers: Prognostic value of 31P-magnetic resonance spectroscopy for early graft function
38. Value of caval effluent in predicting early graft function after orthotopic liver transplantation
39. Hyaluronate levels in donor organ washout effluents: A simple and predictive parameter of graft viability
40. Can effluent hyaluronic acid or creatine kinase predict sinusoidal injury severity after cold ischemia?
41. Creatine kinase-BB: A marker of liver sinusoidal damage in ischemiareperfusion
42. Relationship between early liver graft viability and enzyme activities in effluent preservation solution
43. Endothelin release: A facet of reperfusion injury in clinical liver transplantation?
44. Soluble thrombomodulin: A marker of reperfusion injury after orthotopic liver transplantation
45. Determination of hepatocellular enzymes in effluent of human liver grafts for preoperative evaluation of transplant quality
46. The significance of tissue-type plasminogen activator for pretransplant assessment of liver graft viability: Analysis of effluent from the graft in rats
47. Mediators of fibrinolysis in orthotopic liver transplantation
48. Role of platelets in hepatic allograft preservation injury in the rat
49. Levels of purine compounds in a perfusate as a biochemical marker of ischemic injury of cold-preserved liver
50. Donor des-gamma-carboxy prothrombin positivity is a risk factor for poor early graft function in liver transplantation
51. Evaluation of quantitative liver function tests in liver donors
52. Frozen section evaluation of donor livers before transplantation